PubRank

B Griffith

Author PubWeight™ 42.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Translocation as a species conservation tool: status and strategy. Science 1989 3.31
2 Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A 1990 3.03
3 Status and prospects for success of the endangered species act: a look at recovery plans. Science 1993 1.68
4 Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol 1985 1.65
5 Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol 1990 1.48
6 Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood 1989 1.42
7 Acute disseminated encephalomyelitis (ADEM) or ADEM-like inflammatory changes in a heart-lung transplant recipient: a case report. Neuroradiology 1995 1.39
8 Respiratory sinus arrhythmia in the denervated human heart. J Appl Physiol (1985) 1989 1.39
9 An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X. Nucleic Acids Res 1994 1.15
10 Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team. J Acquir Immune Defic Syndr 1999 1.07
11 Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storage. J Clin Microbiol 1997 1.05
12 Stavudine resistance: an update on susceptibility following prolonged therapy. Antivir Ther 1999 1.04
13 Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med 1993 1.03
14 Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. Transplantation 1997 0.93
15 Long-term mechanical circulatory support system reliability recommendation: American Society for Artificial Internal Organs and The Society of Thoracic Surgeons: long-term mechanical circulatory support system reliability recommendation. Ann Thorac Surg 1998 0.92
16 Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant 1989 0.92
17 The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 2001 0.88
18 Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients. Transplant Proc 1988 0.88
19 Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol 1994 0.88
20 Feasibility of combined percutaneous transluminal angioplasty and minimally invasive direct coronary artery bypass in patients with multivessel coronary artery disease. Circulation 1998 0.87
21 Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc 1998 0.86
22 Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant 1992 0.85
23 Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol 1999 0.85
24 Late follow-up of children after heart transplantation. Transplant Proc 1988 0.84
25 Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation. Transplant Proc 1997 0.84
26 Prediction of rejection in lung transplantation. Transplant Proc 2001 0.83
27 A second case of the acquired immunodeficiency syndrome due to human immunodeficiency virus type 2 in the United States: the clinical implications. Am J Med 1989 0.83
28 Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Association with subsequent histological evidence of allograft rejection. Transplantation 1989 0.82
29 Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts. Transplant Proc 1987 0.81
30 Messenger RNA for glutamine synthetase: its partial purification, translation in a cell-free system and its regulation by hydrocortisone. Biochem Biophys Res Commun 1976 0.81
31 Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans. Transplant Proc 1991 0.80
32 Biological activities of polyethylene-glycol immunoglobulin conjugates. Resistance to enzymatic degradation. J Immunol Methods 1992 0.80
33 Positive, warm T cell crossmatch in cardiac transplantation: with transient vasculitis and without hyperacute rejection. Transplantation 1982 0.78
34 Lung transplantation in patients with scleroderma. J Heart Lung Transplant 2001 0.78
35 Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome. Hum Immunol 2000 0.78
36 In vitro culture of infiltrating lymphocytes from coronary arteries and endomyocardial biopsies: association with graft coronary disease. Transplant Proc 1991 0.77
37 Distinguishing between infection, rejection, and the adult respiratory distress syndrome after human lung transplantation. J Heart Lung Transplant 1992 0.76
38 Lymphocyte activation in bronchoalveolar lavages from heart-lung transplant recipients. Transplant Proc 1988 0.76
39 Phenotypic T-cell changes in thoracic transplant recipients immunosuppressed with FK 506. Transplant Proc 1991 0.75
40 Involuntary and voluntary psychiatric patients: a pilot study of resource consumption. Am J Public Health 1988 0.75
41 Clinical significance of CMV-specific T helper responses in lung transplant recipients. Hum Immunol 1998 0.75
42 Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc 1999 0.75
43 Cell-mediated immunity to donor-specific antigen in heart transplantation. Transplant Proc 1984 0.75
44 Clinical significance of cytomegalovirus-specific T helper responses and cytokine production in lung transplant recipients. Intervirology 1999 0.75
45 Measurement of urinary constituents with the Astra-8 Multichannel Analyzer. Clin Chem 1980 0.75
46 Life in the allogeneic environment after lung transplantation. Lung 1990 0.75
47 Effective early intervention for adolescents harmfully involved in alcohol and drugs. J Fla Med Assoc 1984 0.75
48 Effect of 10 minutes heat treatment on HIV antibody testing from alternate testing sites. Diagn Microbiol Infect Dis 1988 0.75
49 Dynamics of bronchoalveolar lavage in the canine lung transplant. Transplant Proc 1988 0.75
50 Recurrence of a left ventricular thrombus after surgical excision in a young patient with normal left ventricular systolic function--a case report. Angiology 1993 0.75
51 Long-term mechanical circulatory support system reliability recommendation: American Society for Artificial Internal Organs and Society of Thoracic Surgeons: long-term mechanical circulatory support system reliability recommendation. ASAIO J 1998 0.75
52 The HLA matching effect in lung transplantation. Transplantation 1993 0.75
53 A comparative analysis of cytoplasmic mu (C mu) expression in acute lymphoblastic leukemia by molecular and immunologic techniques. Identification of leukemia cases expressing C mu mRNA transcripts in the absence of detectable C mu proteins. Am J Clin Pathol 1992 0.75
54 Bronchoalveolar macrophage-lymphocyte reactivity in heart-lung transplant recipients. Transplant Proc 1987 0.75
55 In vitro studies of endomyocardial biopsies from heart transplant recipients on RATG and OKT3 immunoprophylaxis protocols. Transplantation 1989 0.75
56 Histocompatibility and other rejection risk factors in cardiac transplantation. Transplant Proc 1991 0.75
57 Development of the Nimbus/Pittsburgh axial flow left ventricular assist system. Artif Organs 1997 0.75
58 Histocompatibility in cardiac transplantation with particular reference to immunopathology of positive serologic crossmatch. Clin Immunol Immunopathol 1983 0.75
59 Results of the first 100 patients who received Symbion Total Artificial Hearts as a bridge to cardiac transplantation. Circulation 1989 0.75
60 Right ventricular support after implantation of a Novacor Left Ventricular Assist Device. J Extra Corpor Technol 1992 0.75
61 Competition and containment in health care. Int J Health Serv 2000 0.75
62 Two types of CMV-specific memory responses in lung transplant recipients. Transplant Proc 1999 0.75
63 Cerebrovascular complications associated with the use of artificial circulatory support services. Neurol Clin 1993 0.75
64 Combination therapy of severe rheumatoid arthritis at an early stage of the disease. Schweiz Med Wochenschr Suppl 1996 0.75